Premium
Use of direct oral anticoagulants in thromboembolic disease
Author(s) -
Wilson Matthew R,
Docherty Kieran F,
Gardner Roy S
Publication year - 2016
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1487
Subject(s) - medicine , thromboembolic disease , warfarin , intensive care medicine , disease , atrial fibrillation , thrombosis
Direct oral anticoagulants (DOACs) offer several advantages over warfarin in the management of thromboembolic disease. This article discusses their indications, mode of action, side‐effects and interactions.